KONINKLIJKE PHILIPS NV PHG

Latest FY: 2025 Healthcare Medical Devices
Market Price $27.30
Market Cap $26.07B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.0% YoY
$17.83B
3-Yr CAGR: 0.0%
Net Income ↓-66.7% YoY
$1.00M
Net Margin: 0.0%
Free Cash Flow ↑5.5% YoY
-$449.00M
FCF Yield: -1.72%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 0.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PHG)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $17,422.0M $7,939.0M $43.0M $42.0M
FY 2017 $17,780.0M +2.1% $8,181.0M $214.0M +397.7% $40.0M $-380.0M
FY 2018 $18,121.0M +1.9% $8,554.0M $7.0M -96.7% $35.0M $-387.0M -1.8%
FY 2019 $19,482.0M +7.5% $8,875.0M $5.0M -28.6% $27.0M $-491.0M -26.9%
FY 2020 $19,535.0M +0.3% $8,781.0M $8.0M +60.0% $15.0M $-498.0M -1.4%
FY 2021 $17,156.0M -12.2% $7,168.0M $4.0M -50.0% $17.0M $-380.0M +23.7%
FY 2022 $17,827.0M +3.9% $7,194.0M $3.0M -25.0% $15.0M $-686.0M -80.5%
FY 2023 $18,169.0M +1.9% $7,448.0M $2.0M -33.3% $53.0M $-495.0M +27.8%
FY 2024 $18,021.0M -0.8% $7,773.0M $3.0M +50.0% $83.0M $-475.0M +4.0%
FY 2025 $17,834.0M -1.0% $8,058.0M $1.0M -66.7% $83.0M $-449.0M +5.5%
$

Valuation

Market Price $27.30
Market Cap $26.07B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -1.72%
Dividend Yield N/A
Shares Outstanding 952,018,000
%

Profitability & Margins

Gross Margin 45.18%
Operating Margin 7.98%
Net Margin 0.01%
Return on Equity (ROE) N/A
Return on Assets (ROA) 0.00%
Asset Turnover 0.66x
Revenue 3-Yr CAGR 0.01%
🛡️

Financial Health & Liquidity

Current Ratio 0.34
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $83.00M
Capital Expenditures (CapEx) $532.00M
Free Cash Flow -$449.00M
OCF / Revenue 0.47%
FCF / Revenue -2.52%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $26.94B
Total Liabilities $15.95B
Stockholders' Equity N/A
Current Assets $60.00M
Current Liabilities $174.00M